Medications

New diabetes drug seems safe for heart, study finds

(HealthDay)—The new diabetes drug Onglyza has no effect, good or bad, on a patient's risk for heart attacks, a new study finds. However, the researchers from Brigham and Women's Hospital in Boston did find a surprising ...

Cardiology

Drug-facilitated weight loss benefits cardiometabolic status

(HealthDay)—Obese and overweight patients with dyslipidemia or hypertension treated with phentermine and topiramate extended-release (PHEN/TPM ER) for weight loss had significant improvements in cardiovascular disease risk ...

Cardiology

CVD time bomb set to explode in Gulf region in 10-15 years

With one of the highest rates of obesity in the world, the Gulf region is facing an epidemic of cardiovascular disease. At least 50% of the population is below the age of 25 and the high prevalence of risk factors signals ...

Diseases, Conditions, Syndromes

Liver transplant outcomes no worse with echo abnormalities

(HealthDay)—Intracardiac shunts (ICSs), diagnosed using an echocardiogram, or mild or moderate pulmonary hypertension (PH), do not affect short- or long-term mortality in liver transplant candidates, according to research ...

page 3 from 5